GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Common Stock

Psomagen (XKRX:950200) Common Stock : ₩2,591 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Psomagen Common Stock?

Psomagen's quarterly common stock declined from Sep. 2023 (₩2,586 Mil) to Dec. 2023 (₩2,480 Mil) but then increased from Dec. 2023 (₩2,480 Mil) to Mar. 2024 (₩2,591 Mil).

Psomagen's annual common stock increased from Dec. 2021 (₩2,268 Mil) to Dec. 2022 (₩2,434 Mil) and increased from Dec. 2022 (₩2,434 Mil) to Dec. 2023 (₩2,480 Mil).


Psomagen Common Stock Historical Data

The historical data trend for Psomagen's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Common Stock Chart

Psomagen Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 1,441.61 2,059.21 2,268.28 2,433.86 2,480.30

Psomagen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,503.95 2,524.00 2,585.52 2,480.30 2,590.71

Psomagen Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Psomagen (XKRX:950200) Business Description

Traded in Other Exchanges
N/A
Address
1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850
Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines